INTRODUCTION
+ after infection with a wide variety of viruses. Through secretion of cytokines as well as cytolytic activity, these cells are capable of muting viral replication and reducing the amount of virus present within infected tissue. In recent years, additional activating and inhibitory receptors have been discovered that control both NK cell and CD8 + T-cell activation in response to stress, transformation, and/or infection. In this study, the expression and functional role of the activating receptor NKG2D and its corresponding ligands were determined in viral infection of the central nervous system (CNS). Our data highlight a previously unappreciated role for NKG2D ligand-induced signaling in host defense after viral infection of the CNS by enhancing T-cell effector function and regulating immune-cell trafficking.
THE NKG2D RECEPTOR AND ITS LIGANDS
NKG2D is a type II transmembrane-anchored glycoprotein that is a member of the C-type lectin superfamily. 1 NKG2D receptor ligation by cell-surface glycoprotein ligands that are structurally related to MHC class I molecules results in activation of lymphocytes such as natural killer (NK) cells, CD8 + T cells, and γδ-TcR + T cells. 2, 3 The known mouse NKG2D ligands include the retinoic acid early inducible-1 (RAE-1) proteins (RAE-1 α, β, γ, δ, and ε) 4 , minor histocompatibility antigen H60, 4 and murine UL16-binding protein-like transcript-1 (MULT1) glycoprotein, 5 which are expressed by cells undergoing cellular stress such as viral infection or transformation. 
MHV INFECTION OF THE CNS
Mouse hepatitis virus (MHV) is a positive-strand RNA virus that is a member of the Coronaviridae family. 6 Instillation of MHV into the central nervous system (CNS) of susceptible mice results in an acute encephalomyelitis, followed by a chronic demyelinating disease. 7 Both CD4 + and CD8 + T cells are important in reducing viral burden through secretion of anti-viral cytokines, such as interferon gamma. 8, 9 In addition, cytolytic activity by virus-specific CD8 + T cells is also necessary for viral clearance. 10
NKG2D RECEPTOR AND LIGAND EXPRESSION
NKG2D ligand mRNA transcripts were upregulated within the brains at days 3, 5, 7, and 12 after intracranial (i.c.) infection of BALB/c mice with MHV ( Figure 1A) . Expression of NKG2D receptor was detected on NK cells entering the CNS early after MHV infection. NKG2D receptor was also detected on CD8 + T cells and the frequency of CD8 + T cells expressing the receptor increased over time and ultimately peaked at day 10 p.i. ( Figure 1B) . These data indicate that NKG2D ligand mRNA and receptor are expressed during the course of MHV infection of the CNS.
NKG2D NEUTRALIZATION IN IMMUNOCOMPETENT MICE
NKG2D neutralization in MHV-infected BALB/c mice resulted in a dramatic decrease in survival compared with mice treated with a control antibody (Figure 2A ). Mice treated with anti-NKG2D had increased viral titers at 7 and 12 days p.i., when compared with control mice. Moreover, anti-NKG2D treatment did result in a reduction in NK cells, T cells, and macrophages. IFN-γ secretion was also reduced in anti-NKG2D treated mice and These data demonstrate that NKG2D signaling is required for generation of an efficient immune response in the CNS of immunocompetent mice infected with MHV.
CONCLUSIONS
This study demonstrated that after MHV infection, NKG2D ligands are up-regulated within the CNS and infiltrating NK cells and CD8 + T cells express the NKG2D receptor. NKG2D neutralization in BALB/c mice resulted in reduced survival and diminished immune cell infiltration accompanied by decreased IFN-γ secretion that correlated with increased viral titers in the CNS. In addition, anti-NKG2D neutralization hampered the host's ability to mount an efficient immune response, demonstrating that NKG2D signaling is important in this model of viral-induced CNS disease.
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